Opaleye Management Inc. Chemo Centryx, Inc. Transaction History

Opaleye Management Inc.

$390 Million
Q2 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 May 18, 2021	SELL	$49.53 - $68.4 $17.3 Million - $23.9 Million	-350,000 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$47.25 - $65.16 $283,500 - $390,960	-6,000 Reduced 1.69%	350,000 $21.7 Million
Q3 2020 Nov 16, 2020	SELL	$46.35 - $61.69 $259,560 - $345,464	-5,600 Reduced 1.55%	356,000 $19.5 Million
Q4 2019 Feb 14, 2020	BUY	$6.81 - $39.55 $1.1 Million - $6.39 Million	161,600 Added 80.8%	361,600 $13.8 Million
Q3 2019 Nov 14, 2019	BUY	$6.47 - $8.96 $1.29 Million - $1.79 Million	200,000 New	200,000 $1.36 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.